Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous PBSC Transplant for Myelofibrosis
NCT00006367Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- May 2000
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of busulfan in myelofibrosis (MF), sponsored by Fred Hutchinson Cancer Center. Started May 2000; status: completed.
02
Drugs
busulfan
03
Conditions
myelofibrosis (MF)
Beyond the preview
Go deeper on NCT00006367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006367.